[Interleukin-2 in oncology].
Triebel
F
F
Laboratoire d'hémato-immunologie, INSERM U333, Institut Gustave-Roussy, Villejuif.
Hercend
T
T
D000818:Animals; D003131:Combined Modality Therapy; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D017710:Lymphocyte Transfusion; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*
D007376:Interleukin-2